Bicara Therapeutics Inc. Patent Applications Pending
13 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-03-15: Application 18607049; Invention CAIX TARGETING IL-12 FUSION PROTEINS AND METHODS OF USE THEREOF; Applicant BICARA THERAPEUTICS INC.; Status Docketed New Case - Ready for Examination.
- 2024-02-06: Application PCTUS2024014543; Invention COMBINATION THERAPY AND RELATED METHODS; Applicant BICARA THERAPEUTICS INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2024-02-06: Application 18433814; Invention COMBINATION THERAPY AND RELATED METHODS; Applicant Bicara Therapeutics Inc.; Status Docketed New Case - Ready for Examination.
- 2023-10-05: Application PCTUS2023076043; Invention MULTISPECIFIC PROTEINS AND RELATED METHODS; Applicant BICARA THERAPEUTICS INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2024-03-15 | 18607049 | CAIX TARGETING IL-12 FUSION PROTEINS AND METHODS OF USE THEREOF | BICARA THERAPEUTICS INC. | Docketed New Case - Ready for Examination | US20240392031A1 | Jaya BHATNAGAR Arvind Vittal GOSWAMI Harish Kumar TRIPURANA Pradip NAIR Ramakrishnan Melarkode SUBBARAMAN Shiv Ram KRISHN Srinivas Reddy BOREDDY Reshmi NAIR Avanish K. VARSHNEY Seng-Lai TAN | India India India India India India India India United States United States | NATARAJAN, MEERA |
| 2024-02-06 | PCTUS2024014543 | COMBINATION THERAPY AND RELATED METHODS | BICARA THERAPEUTICS INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | RACHEL SALAZAR PRADIP NAIR SRINIVAS REDDY BOREDDY PRASHANT KUMAR PANDEY PRASHANTHA KUMARA M. V | United States United States United States United States United States | ||
| 2024-02-06 | 18433814 | COMBINATION THERAPY AND RELATED METHODS | Bicara Therapeutics Inc. | Docketed New Case - Ready for Examination | US20240343813A1 | Rachel SALAZAR Pradip NAIR Srinivas Reddy BOREDDY Prashant Kumar PANDEY Prashantha KUMARA M. V | United States India India India India | ROONEY, NORA MAUREEN |
| 2023-10-05 | PCTUS2023076043 | MULTISPECIFIC PROTEINS AND RELATED METHODS | BICARA THERAPEUTICS INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ARVIND VITTAL GOSWAMI JAYA BHATNAGAR RESHMI NAIR VEENA SOMASUNDARAM SENG-LAI TAN AVANISH KUMAR VARSHNEY | United States United States United States United States United States United States | ||
| 2023-10-05 | 18481511 | MULTISPECIFIC PROTEINS AND RELATED METHODS | Bicara Therapeutics Inc. | Response to Non-Final Office Action Entered and Forwarded to Examiner | US20240228620A1 | Arvind Vittal GOSWAMI Jaya BHATNAGAR Reshmi NAIR Veena SOMASUNDARAM Seng-Lai TAN Avanish Kumar VARSHNEY | India India India India United States United States | NATARAJAN, MEERA |
| 2023-06-09 | 18256761 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | BICARA THERAPEUTICS INC. | Publications -- Issue Fee Payment Verified | US20240082394A1 | Shivakumar Bhadravathi MARIGOWDA Madhukara A R Prashant Kumar PANDEY Srinivas Reddy BOREDDY Pradip NAIR | India India India India India | CHANDRA, GYAN |
| 2023-06-09 | 18256748 | PHARMACEUTICAL FORMULATIONS FOR FUSION PROTEINS | BICARA THERAPEUTICS INC. | Response to Non-Final Office Action Entered and Forwarded to Examiner | US20240084018A1 | Rahul Dnyandeo JANGLE Kavitha S. RAO Pradeep JADIYAPPA Sucharitha JAYAKAR | India India India India | CUNNINGCHEN, KATHLEEN MARY |
| 2023-02-06 | 63483399 | COMBINATION THERAPY AND RELATED METHODS | Bicara Therapeutics Inc. | Provisional Application Expired | Rachel SALAZAR Pradip NAIR Srinivas Reddy BOREDDY Prashant Kumar PANDEY Prashantha KUMARA M. V | United States India India India India | ||
| 2022-10-06 | 63413765 | MULTISPECIFIC PROTEINS AND RELATED METHODS | Bicara Therapeutics Inc. | Provisional Application Expired | Arvind Vittal GOSWAMI Jaya BHATNAGAR Reshmi NAIR Veena SOMASUNDARAM Seng-Lai TAN Avanish Kumar VARSHNEY | India India India India United States United States | ||
| 2022-09-16 | PCTUS2022043762 | CAIX TARGETING IL-12 FUSION PROTEINS AND METHODS OF USE THEREOF | BICARA THERAPEUTICS INC. | PCT - International Search Report Mailed to IB | JAYA BHATNAGAR ARVIND VITTAL GOSWAMI HARISH KUMAR TRIPURANA PRADIP NAIR RAMAKRISHNAN MELARKODE SUBBARAMAN SHIV RAM KRISHN SRINIVAS REDDY BOREDDY RESHMI NAIR AVANISH K. VARSHNEY SENG-LAI TAN | India India India India India India India India United States United States | THOMAS, SHANE M | |
| 2021-12-15 | PCTUS2021010067 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | BICARA THERAPEUTICS INC. | PCT - International Search Report Mailed to IB | PRASHANT KUMAR PANDEY MADHUKARA AR SRINIVAS REDDY BOREDDY PRADIP NAIR SHIVAKUMAR BHADRAVATHI MARIGOWDA | India India India India India | THOMAS, SHANE M | |
| 2021-12-15 | PCTUS2021010066 | PHARMACEUTICAL FORMULATIONS FOR FUSION PROTEINS | BICARA THERAPEUTICS INC. | PCT - International Search Report Mailed to IB | RAHUL DNYANDEO JANLE KAVITHA S. RAO SUCHARITHA JAYAKAR PRADEEP JADIYAPPA | India India India India | THOMAS, SHANE M | |
| 2021-09-17 | 63245523 | CAIX TARGETING FUSION PROTEINS AND METHODS OF USE THEREOF | Bicara Therapeutics Inc. | Provisional Application Expired | Seng-Lai Tan Jaya Bhatnagar Arvind Vittal Goswami Harish Kumar Tripurana Pradip Nair Ramakrishnan Melarkode Subbaraman Avanish K. Varshney | United States India India India India India United States |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |